Literature DB >> 23135867

A girl with difficult lupus nephritis: lupus vasculopathy.

Alison Lap-tak Ma1, Wai-ming Lai, Man-Chun Chiu, Niko Kei-chiu Tse.   

Abstract

Lupus vasculopathy (LV) is one of the complications of lupus nephritis. No definite therapy has been recommended for the management of LV, and patient outcomes are variable. We present the case of a 16-year-old girl who recovered from stage V chronic kidney disease due to lupus nephritis with vasculopathy with active treatment including pulse methylprednisolone, cyclophosphamide, rituximab and plasma exchange.

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 23135867     DOI： 10.1007/s10157-012-0720-5

Source DB:  PubMed          Journal:  Clin Exp Nephrol        ISSN： 1342-1751            Impact factor:   2.801


  8 in total

1.  Massive uncomplicated vascular immune complex deposits in the kidney of a patient with systemic lupus erythematosus.

Authors:  K Takazoe; T Shimada; H Nakano; T Kawamura; Y Utsunomiya; T Kanai; T Kitajima; Y Yamaguchi; K Joh; T Mitarai; O Sakai
Journal:  Clin Nephrol       Date:  1997-09       Impact factor: 0.975

Review 2.  Renal pathology of human immunodeficiency virus infection.

Authors:  V D'Agati; G B Appel
Journal:  Semin Nephrol       Date:  1998-07       Impact factor: 5.299

3.  Renal vascular lesions in lupus nephritis.

Authors:  E Descombes; D Droz; L Drouet; J P Grünfeld; P Lesavre
Journal:  Medicine (Baltimore)       Date:  1997-09       Impact factor: 1.889

4.  Rituximab is an effective treatment for lupus nephritis and allows a reduction in maintenance steroids.

Authors:  Ruth Pepper; Megan Griffith; Chris Kirwan; Jeremy Levy; David Taube; Charles Pusey; Liz Lightstone; Tom Cairns
Journal:  Nephrol Dial Transplant       Date:  2009-07-17       Impact factor: 5.992

5.  Lupus vasculopathy combined with acute renal failure in lupus nephritis.

Authors:  Chien-Te Wu; Lin-Shien Fu; Mei-Chin Wen; Shein-Chung Hung; Ching-Shiang Chi
Journal:  Pediatr Nephrol       Date:  2003-10-24       Impact factor: 3.714

6.  Renal vascular lesions as a marker of poor prognosis in patients with lupus nephritis. Gruppo Italiano per lo Studio della Nefrite Lupica (GISNEL).

Authors:  G Banfi; T Bertani; V Boeri; T Faraggiana; G Mazzucco; G Monga; G Sacchi
Journal:  Am J Kidney Dis       Date:  1991-08       Impact factor: 8.860

7.  Is combination rituximab with cyclophosphamide better than rituximab alone in the treatment of lupus nephritis?

Authors:  Edmund K Li; Lai-Shan Tam; Tracy Y Zhu; Martin Li; Catherine L Kwok; Tena K Li; Ying Ying Leung; Kong Chiu Wong; Cheuk Chun Szeto
Journal:  Rheumatology (Oxford)       Date:  2009-05-28       Impact factor: 7.580

8.  Systemic lupus erythematosus presented as non-inflammatory necrotizing vasculopathy-induced ischemic glomerulopathy and small vessels-related ischemic cardiomyopathy.

Authors:  J M Sung; S C Hsu; F F Chen; J J Huang
Journal:  Lupus       Date:  2002       Impact factor: 2.911
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.